Press MF - Search Results

1

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.

Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, Jenkins RB, Press MF, Spears PA, Vance GH, Viale G, McShane LM, Dowsett M. Wolff AC, et al. Among authors: press mf. J Clin Oncol. 2018 Jul 10;36(20):2105-2122. doi: 10.1200/JCO.2018.77.8738. Epub 2018 May 30. J Clin Oncol. 2018. PMID: 29846122 Free article.

2

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, et al. Press MF, et al. Cancer Res. 1993 Oct 15;53(20):4960-70. Cancer Res. 1993. PMID: 8104689

3

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ. Pauletti G, et al. Among authors: press mf. Oncogene. 1996 Jul 4;13(1):63-72. Oncogene. 1996. PMID: 8700555

4

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

5

Telomerase activity in normal and neoplastic breast.

Tsao Jl, Zhao Y, Lukas J, Yang X, Shah A, Press M, Shibata D. Tsao Jl, et al. Clin Cancer Res. 1997 Apr;3(4):627-31. Clin Cancer Res. 1997. PMID: 9815730

6

Clonal analysis of bilateral breast cancer.

Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK. Shibata A, et al. Among authors: press mf. Clin Cancer Res. 1996 Apr;2(4):743-8. Clin Cancer Res. 1996. PMID: 9816225

7

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M. Vogel CL, et al. J Clin Oncol. 2002 Feb 1;20(3):719-26. doi: 10.1200/JCO.2002.20.3.719. J Clin Oncol. 2002. PMID: 11821453 Corrected and republished. Clinical Trial.

8

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Press MF, et al. J Clin Oncol. 2002 Jul 15;20(14):3095-105. doi: 10.1200/JCO.2002.09.094. J Clin Oncol. 2002. PMID: 12118023

9

Comparison of different antibodies for detection of progesterone receptor in breast cancer.

Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L, Christensen K, Edwards DP. Press M, et al. Steroids. 2002 Aug;67(9):799-813. doi: 10.1016/s0039-128x(02)00039-9. Steroids. 2002. PMID: 12123792

10

P7 antigen expression in human breast cancer.

Yang X, Groshen S, Formenti SC, Davidson NE, Press MF. Yang X, et al. Among authors: press mf. Clin Cancer Res. 2003 Jan;9(1):201-6. Clin Cancer Res. 2003. PMID: 12538470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page